Drugs that bind to and activate cholinergic receptors.
Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here.
Drugs that bind to and activate muscarinic cholinergic receptors (RECEPTORS, MUSCARINIC). Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate.
Any drug used for its actions on cholinergic systems. Included here are agonists and antagonists, drugs that affect the life cycle of ACETYLCHOLINE, and drugs that affect the survival of cholinergic neurons. The term cholinergic agents is sometimes still used in the narrower sense of MUSCARINIC AGONISTS, although most modern texts discourage that usage.
One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for MUSCARINE over NICOTINE. There are several subtypes (usually M1, M2, M3....) that are characterized by their cellular actions, pharmacology, and molecular biology.
A slowly hydrolyzing muscarinic agonist with no nicotinic effects. Bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, HEART RATE changes, and BRONCHIAL SPASM.
A non-hydrolyzed muscarinic agonist used as a research tool.
An alkaloid, originally from Atropa belladonna, but found in other plants, mainly SOLANACEAE. Hyoscyamine is the 3(S)-endo isomer of atropine.
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system.
A neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system.
An alkaloid obtained from the betel nut (Areca catechu), fruit of a palm tree. It is an agonist at both muscarinic and nicotinic acetylcholine receptors. It is used in the form of various salts as a ganglionic stimulant, a parasympathomimetic, and a vermifuge, especially in veterinary practice. It has been used as a euphoriant in the Pacific Islands.
A toxic alkaloid found in Amanita muscaria (fly fungus) and other fungi of the Inocybe species. It is the first parasympathomimetic substance ever studied and causes profound parasympathetic activation that may end in convulsions and death. The specific antidote is atropine.
Compounds containing the PhCH= radical.
Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology.
Drugs that bind to and activate nicotinic cholinergic receptors (RECEPTORS, NICOTINIC). Nicotinic agonists act at postganglionic nicotinic receptors, at neuroeffector junctions in the peripheral nervous system, and at nicotinic receptors in the central nervous system. Agents that function as neuromuscular depolarizing blocking agents are included here because they activate nicotinic receptors, although they are used clinically to block nicotinic transmission.
Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists.
One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for NICOTINE over MUSCARINE. They are generally divided into muscle-type and neuronal-type (previously ganglionic) based on pharmacology, and subunit composition of the receptors.
Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke.
A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity.
The tear-forming and tear-conducting system which includes the lacrimal glands, eyelid margins, conjunctival sac, and the tear drainage system.
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS.
A high-affinity muscarinic antagonist commonly used as a tool in animal and tissue studies.
A specific subtype of muscarinic receptor that has a high affinity for the drug PIRENZEPINE. It is found in the peripheral GANGLIA where it signals a variety of physiological functions such as GASTRIC ACID secretion and BRONCHOCONSTRICTION. This subtype of muscarinic receptor is also found in neuronal tissues including the CEREBRAL CORTEX and HIPPOCAMPUS where it mediates the process of MEMORY and LEARNING.
Compounds that contain the decamethylenebis(trimethyl)ammonium radical. These compounds frequently act as neuromuscular depolarizing agents.
Drugs that bind to and activate adrenergic receptors.
A selective nicotinic cholinergic agonist used as a research tool. DMPP activates nicotinic receptors in autonomic ganglia but has little effect at the neuromuscular junction.
A region extending from the PONS & MEDULLA OBLONGATA through the MESENCEPHALON, characterized by a diversity of neurons of various sizes and shapes, arranged in different aggregations and enmeshed in a complicated fiber network.
A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.
Drugs that bind to and activate dopamine receptors.
A member of the NICOTINIC ACETYLCHOLINE RECEPTOR subfamily of the LIGAND-GATED ION CHANNEL family. It consists entirely of pentameric a7 subunits expressed in the CNS, autonomic nervous system, vascular system, lymphocytes and spleen.
A group of compounds that are derivatives of beta-methylacetylcholine (methacholine).
A subclass of muscarinic receptor that mediates cholinergic-induced contraction in a variety of SMOOTH MUSCLES.
A form of phagocyte bactericidal dysfunction characterized by unusual oculocutaneous albinism, high incidence of lymphoreticular neoplasms, and recurrent pyogenic infections. In many cell types, abnormal lysosomes are present leading to defective pigment distribution and abnormal neutrophil functions. The disease is transmitted by autosomal recessive inheritance and a similar disorder occurs in the beige mouse, the Aleutian mink, and albino Hereford cattle.
The front part of the hindbrain (RHOMBENCEPHALON) that lies between the MEDULLA and the midbrain (MESENCEPHALON) ventral to the cerebellum. It is composed of two parts, the dorsal and the ventral. The pons serves as a relay station for neural pathways between the CEREBELLUM to the CEREBRUM.
The relationship between the dose of an administered drug and the response of the organism to the drug.
An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6)
Agents affecting the function of, or mimicking the actions of, the autonomic nervous system and thereby having an effect on such processes as respiration, circulation, digestion, body temperature regulation, certain endocrine gland secretions, etc.
The craniosacral division of the autonomic nervous system. The cell bodies of the parasympathetic preganglionic fibers are in brain stem nuclei and in the sacral spinal cord. They synapse in cranial autonomic ganglia or in terminal ganglia near target organs. The parasympathetic nervous system generally acts to conserve resources and restore homeostasis, often with effects reciprocal to the sympathetic nervous system.
Nerve fibers liberating acetylcholine at the synapse after an impulse.
Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system.
A basic element found in nearly all organized tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes.
An alkaloid from SOLANACEAE, especially DATURA and SCOPOLIA. Scopolamine and its quaternary derivatives act as antimuscarinics like ATROPINE, but may have more central nervous system effects. Among the many uses are as an anesthetic premedication, in URINARY INCONTINENCE, in MOTION SICKNESS, as an antispasmodic, and as a mydriatic and cycloplegic.
A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
Use of electric potential or currents to elicit biological responses.
Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
A glandular epithelial cell or a unicellular gland. Goblet cells secrete MUCUS. They are scattered in the epithelial linings of many organs, especially the SMALL INTESTINE and the RESPIRATORY TRACT.
The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization).
A stage of sleep characterized by rapid movements of the eye and low voltage fast pattern EEG. It is usually associated with dreaming.
A neuromuscular blocker and active ingredient in CURARE; plant based alkaloid of Menispermaceae.
Neurotoxic proteins from the venom of the banded or Formosan krait (Bungarus multicinctus, an elapid snake). alpha-Bungarotoxin blocks nicotinic acetylcholine receptors and has been used to isolate and study them; beta- and gamma-bungarotoxins act presynaptically causing acetylcholine release and depletion. Both alpha and beta forms have been characterized, the alpha being similar to the large, long or Type II neurotoxins from other elapid venoms.
Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.
A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
Endogenous compounds and drugs that bind to and activate GAMMA-AMINOBUTYRIC ACID receptors (RECEPTORS, GABA).
Sweat-producing structures that are embedded in the DERMIS. Each gland consists of a single tube, a coiled body, and a superficial duct.
An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH.
The discharge of saliva from the SALIVARY GLANDS that keeps the mouth tissues moist and aids in digestion.
Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses.
A group of amylolytic enzymes that cleave starch, glycogen, and related alpha-1,4-glucans. (Stedman, 25th ed) EC 3.2.1.-.
A quaternary ammonium parasympathomimetic agent with the muscarinic actions of ACETYLCHOLINE. It is hydrolyzed by ACETYLCHOLINESTERASE at a considerably slower rate than ACETYLCHOLINE and is more resistant to hydrolysis by nonspecific CHOLINESTERASES so that its actions are more prolonged. It is used as a parasympathomimetic bronchoconstrictor agent and as a diagnostic aid for bronchial asthma. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1116)
A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain.
Compounds that bind to and stimulate PURINERGIC P1 RECEPTORS.
Abrupt changes in the membrane potential that sweep along the CELL MEMBRANE of excitable cells in response to excitation stimuli.
The largest of the three pairs of SALIVARY GLANDS. They lie on the sides of the FACE immediately below and in front of the EAR.
The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.
In about 250 species of electric fishes, modified muscle fibers forming disklike multinucleate plates arranged in stacks like batteries in series and embedded in a gelatinous matrix. A large torpedo ray may have half a million plates. Muscles in different parts of the body may be modified, i.e., the trunk and tail in the electric eel, the hyobranchial apparatus in the electric ray, and extrinsic eye muscles in the stargazers. Powerful electric organs emit pulses in brief bursts several times a second. They serve to stun prey and ward off predators. A large torpedo ray can produce of shock of more than 200 volts, capable of stunning a human. (Storer et al., General Zoology, 6th ed, p672)
A specific subtype of muscarinic receptor found in the lower BRAIN, the HEART and in SMOOTH MUSCLE-containing organs. Although present in smooth muscle the M2 muscarinic receptor appears not to be involved in contractile responses.
The injection of very small amounts of fluid, often with the aid of a microscope and microsyringes.
A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
A highly basic, 28 amino acid neuropeptide released from intestinal mucosa. It has a wide range of biological actions affecting the cardiovascular, gastrointestinal, and respiratory systems and is neuroprotective. It binds special receptors (RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE).
Therapeutic introduction of ions of soluble salts into tissues by means of electric current. In medical literature it is commonly used to indicate the process of increasing the penetration of drugs into surface tissues by the application of electric current. It has nothing to do with ION EXCHANGE; AIR IONIZATION nor PHONOPHORESIS, none of which requires current.
The communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES.
An electrophysiologic technique for studying cells, cell membranes, and occasionally isolated organelles. All patch-clamp methods rely on a very high-resistance seal between a micropipette and a membrane; the seal is usually attained by gentle suction. The four most common variants include on-cell patch, inside-out patch, outside-out patch, and whole-cell clamp. Patch-clamp methods are commonly used to voltage clamp, that is control the voltage across the membrane and measure current flow, but current-clamp methods, in which the current is controlled and the voltage is measured, are also used.
A genus of the Torpedinidae family consisting of several species. Members of this family have powerful electric organs and are commonly called electric rays.
The rate dynamics in chemical or physical systems.
An enzyme that catalyzes the hydrolysis of ACETYLCHOLINE to CHOLINE and acetate. In the CNS, this enzyme plays a role in the function of peripheral neuromuscular junctions. EC
Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS.
The study of the generation and behavior of electrical charges in living organisms particularly the nervous system and the effects of electricity on living organisms.
Elements of limited time intervals, contributing to particular results or situations.
Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT2 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT2 receptor subtypes.
A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation.
The function of opposing or restraining the excitation of neurons or their target excitable cells.
An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters.
Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes.
Projection neurons in the CEREBRAL CORTEX and the HIPPOCAMPUS. Pyramidal cells have a pyramid-shaped soma with the apex and an apical dendrite pointed toward the pial surface and other dendrites and an axon emerging from the base. The axons may have local collaterals but also project outside their cortical region.
Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically.
A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research.
Phosphoric acid esters of inositol. They include mono- and polyphosphoric acid esters, with the exception of inositol hexaphosphate which is PHYTIC ACID.
Compounds that bind to and stimulate PURINERGIC P2 RECEPTORS.
The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway.
Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed)
Drugs that selectively bind to and activate beta-adrenergic receptors.
Condensed areas of cellular material that may be bounded by a membrane.
Endogenous compounds and drugs that bind to and activate GABA-A RECEPTORS.
Regulatory proteins that act as molecular switches. They control a wide range of biological processes including: receptor signaling, intracellular signal transduction pathways, and protein synthesis. Their activity is regulated by factors that control their ability to bind to and hydrolyze GTP to GDP. EC 3.6.1.-.
The increase in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical.
The most common inhibitory neurotransmitter in the central nervous system.
Compounds that bind to and stimulate ADENOSINE A1 RECEPTORS.
An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding.
Drugs that selectively bind to and activate alpha adrenergic receptors.
Depolarization of membrane potentials at the SYNAPTIC MEMBRANES of target neurons during neurotransmission. Excitatory postsynaptic potentials can singly or in summation reach the trigger threshold for ACTION POTENTIALS.
Specialized junctions at which a neuron communicates with a target cell. At classical synapses, a neuron's presynaptic terminal releases a chemical transmitter stored in synaptic vesicles which diffuses across a narrow synaptic cleft and activates receptors on the postsynaptic membrane of the target cell. The target may be a dendrite, cell body, or axon of another neuron, or a specialized region of a muscle or secretory cell. Neurons may also communicate via direct electrical coupling with ELECTRICAL SYNAPSES. Several other non-synaptic chemical or electric signal transmitting processes occur via extracellular mediated interactions.
Compounds that bind to and activate ADRENERGIC ALPHA-1 RECEPTORS.
Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed)
Refers to animals in the period of time just after birth.
Drugs that bind to and activate excitatory amino acid receptors.
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.
Compounds that interact with and stimulate the activity of CANNABINOID RECEPTORS.
A phorbol ester found in CROTON OIL with very effective tumor promoting activity. It stimulates the synthesis of both DNA and RNA.
Compounds that bind to and activate ADRENERGIC BETA-3 RECEPTORS.
A class of opioid receptors recognized by its pharmacological profile. Mu opioid receptors bind, in decreasing order of affinity, endorphins, dynorphins, met-enkephalin, and leu-enkephalin. They have also been shown to be molecular receptors for morphine.
The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells.
Drugs that selectively bind to and activate ADENOSINE A3 RECEPTORS.
A class of opioid receptors recognized by its pharmacological profile. Kappa opioid receptors bind dynorphins with a higher affinity than endorphins which are themselves preferred to enkephalins.
Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders).
Endogenous compounds and drugs that bind to and activate GABA-B RECEPTORS.
A class of opioid receptors recognized by its pharmacological profile. Delta opioid receptors bind endorphins and enkephalins with approximately equal affinity and have less affinity for dynorphins.
Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT4 RECEPTORS.
A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed)
Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.
A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D2-class receptor genes contain INTRONS, and the receptors inhibit ADENYLYL CYCLASES.
An enkephalin analog that selectively binds to the MU OPIOID RECEPTOR. It is used as a model for drug permeability experiments.
Compounds that bind to and activate PURINERGIC RECEPTORS.
A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.
Cell membrane proteins that bind opioids and trigger intracellular changes which influence the behavior of cells. The endogenous ligands for opioid receptors in mammals include three families of peptides, the enkephalins, endorphins, and dynorphins. The receptor classes include mu, delta, and kappa receptors. Sigma receptors bind several psychoactive substances, including certain opioids, but their endogenous ligands are not known.
Compounds that bind to and activate ADRENERGIC BETA-1 RECEPTORS.
A family of hexahydropyridines.
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS.

Modulation of long-term synaptic depression in visual cortex by acetylcholine and norepinephrine. (1/652)

In a slice preparation of rat visual cortex, we discovered that paired-pulse stimulation (PPS) elicits a form of homosynaptic long-term depression (LTD) in the superficial layers when carbachol (CCh) or norepinephrine (NE) is applied concurrently. PPS by itself, or CCh and NE in the absence of synaptic stimulation, produced no lasting change. The LTD induced by PPS in the presence of NE or CCh is of comparable magnitude with that obtained with prolonged low-frequency stimulation (LFS) but requires far fewer stimulation pulses (40 vs 900). The cholinergic facilitation of LTD was blocked by atropine and pirenzepine, suggesting involvement of M1 receptors. The noradrenergic facilitation of LTD was blocked by urapidil and was mimicked by methoxamine, suggesting involvement of alpha1 receptors. beta receptor agonists and antagonists were without effect. Induction of LTD by PPS was inhibited by NMDA receptor blockers (completely in the case of NE; partially in the case of CCh), suggesting that one action of the modulators is to control the gain of NMDA receptor-dependent homosynaptic LTD in visual cortex. We propose that this is a mechanism by which cholinergic and noradrenergic inputs to the neocortex modulate naturally occurring receptive field plasticity.  (+info)

Metrifonate increases neuronal excitability in CA1 pyramidal neurons from both young and aging rabbit hippocampus. (2/652)

The effects of metrifonate, a second generation cholinesterase inhibitor, were examined on CA1 pyramidal neurons from hippocampal slices of young and aging rabbits using current-clamp, intracellular recording techniques. Bath perfusion of metrifonate (10-200 microM) dose-dependently decreased both postburst afterhyperpolarization (AHP) and spike frequency adaptation (accommodation) in neurons from young and aging rabbits (AHP: p < 0.002, young; p < 0.050, aging; accommodation: p < 0.024, young; p < 0.001, aging). These reductions were mediated by muscarinic cholinergic transmission, because they were blocked by addition of atropine (1 microM) to the perfusate. The effects of chronic metrifonate treatment (12 mg/kg for 3 weeks) on CA1 neurons of aging rabbits were also examined ex vivo. Neurons from aging rabbits chronically treated with metrifonate had significantly reduced spike frequency accommodation, compared with vehicle-treated rabbits. Chronic metrifonate treatment did not result in a desensitization to metrifonate ex vivo, because bath perfusion of metrifonate (50 microM) significantly decreased the AHP and accommodation in neurons from both chronically metrifonate- and vehicle-treated aging rabbits. We propose that the facilitating effect of chronic metrifonate treatment on acquisition of hippocampus-dependent tasks such as trace eyeblink conditioning by aging subjects may be caused by this increased excitability of CA1 pyramidal neurons.  (+info)

Influence of nitric oxide modulators on cholinergically stimulated hormone release from mouse islets. (3/652)

1. We have investigated, with a combined in vitro and in vivo approach, the influence on insulin and glucagon release stimulated by the cholinergic, muscarinic agonist carbachol of different NO modulators, i.e. the nitric oxide synthase (NOS) inhibitors NG-nitro-L-arginine methyl ester (L-NAME), NG-monomethyl-L-arginine (L-NMMA) and 7-nitroindazole as well as the intracellular NO donor hydroxylamine. 2. At basal glucose (7 mM) carbachol dose-dependently stimulated insulin release from isolated islets with a half-maximal response at approximately 1 microM of the agonist. In the presence of 5 mM L-NAME (a concentration that did not influence basal insulin release) the insulin response was markedly increased along the whole dose-response curve and the threshold for carbachol stimulation was significantly lowered. 3. Carbachol-stimulated islets displayed an increased insulin release and a suppressed glucagon release in the presence of L-NAME, L-NMMA or 7-nitroindazole. Significant suppression of glucagon release (except for L-NAME) was achieved at lower concentrations (approximately 0.1-0.5 mM) of the NOS inhibitors than the potentiation of insulin release (1.0-5.0 mM). The intracellular NO donor hydroxylamine dose-dependently inhibited carbachol-induced insulin release but stimulated glucagon release only at a low concentration (3 microM). 4. In islets depolarized with 30 mM K+ in the presence of the KATP channel opener diazoxide, NOS inhibition by 5 mM L-NAME still markedly potentiated carbachol-induced insulin release (although less so than in normal islets) and suppressed glucagon release. 5. In vivo pretreatment of mice with L-NAME was followed by a markedly increased insulin release and a reduced glucagon release in response to an i.v. injection of carbachol. 6. The data suggest that NO is a negative modulator of insulin release but a positive modulator of glucagon release induced by cholinergic muscarinic stimulation. These effects were also evident in K+ depolarized islets and thus NO might exert a major influence on islet hormone secretion independently of membrane depolarization events.  (+info)

Miniglucagon (glucagon 19-29), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathway. (4/652)

Using the MIN6 B-cell line, we investigated the hypothesis that miniglucagon, the C-terminal () fragment processed from glucagon and present in pancreatic A cells, modulates insulin release, and we analyzed its cellular mode of action. We show that, at concentrations ranging from 0.01 to 1000 pM, miniglucagon dose-dependently (ID50 = 1 pM) inhibited by 80-100% the insulin release triggered by glucose, glucagon, glucagon-like peptide-1-(7-36) amide (tGLP-1), or glibenclamide, but not that induced by carbachol. Miniglucagon had no significant effects on cellular cAMP levels. The increase in 45Ca2+ uptake induced by depolarizing agents (glucose or extracellular K+), by glucagon, or by the Ca2+channel agonist Bay K-8644 was blocked by miniglucagon at the doses active on insulin release. Electrophysiological experiments indicated that miniglucagon induces membrane hyperpolarization, probably by opening potassium channels, which terminated glucose-induced electrical activity. Pretreatment with pertussis toxin abolished the effects of miniglucagon on insulin release. It is concluded that miniglucagon is a highly potent and efficient inhibitor of insulin release by closing, via hyperpolarization, voltage-dependent Ca2+ channels linked to a pathway involving a pertussis toxin-sensitive G protein.  (+info)

Cholinergic and GABAergic regulation of nitric oxide synthesis in the guinea pig ileum. (5/652)

Nitric oxide (NO) synthesis was examined in intact longitudinal muscle-myenteric plexus preparations of the guinea pig ileum by determining the formation of [3H]citrulline during incubation with [3H]arginine. Spontaneous [3H]citrulline production after 30 min was 80-90 dpm/mg, which constituted approximately 1% of the tissue radioactivity. Electrical stimulation (10 Hz) led to a threefold increase in [3H]citrulline formation. Removal of calcium from the medium or addition of NG-nitro-L-arginine strongly inhibited both spontaneous and electrically induced production of [3H]citrulline. TTX reduced the electrically induced but not spontaneous [3H]citrulline formation. The electrically induced formation of [3H]citrulline was diminished by (+)-tubocurarine and mecamylamine and enhanced by scopolamine, which suggests that endogenous ACh inhibits, via muscarinic receptors, and stimulates, via nicotinic receptors, the NO synthesis in the myenteric plexus. The GABAA receptor agonist muscimol and GABA also reduced the electrically evoked formation of [3H]citrulline, whereas baclofen was without effect. Bicuculline antagonized the inhibitory effect of GABA. It is concluded that nitrergic myenteric neurons are equipped with GABAA receptors, which mediate inhibition of NO synthesis.  (+info)

Purinergic and cholinergic agonists induce exocytosis from the same granule pool in HT29-Cl.16E monolayers. (6/652)

Several secretagogues induce mucin secretion in epithelial monolayers, as determined by measuring released granule contents. To assess whether different agonists act on the same granule pool, capacitance changes in intact monolayers of the goblet cell line HT29-Cl.16E were measured by a novel impedance method. Apical ATP (purinergic agonist) and basolateral carbachol (cholinergic agonist) induce rapid exocytosis with maximal capacitance changes within 3 min. The maximal levels of exocytosis that can be induced by optimal concentrations of either agonist are the same and produce a 30-40% increase in total monolayer capacitance. When ATP and carbachol are applied simultaneously, the magnitude of exocytosis is unchanged from the single-secretagogue level. The recovery of capacitance to baseline (endocytosis) is significantly faster after ATP stimulation than after carbachol stimulation. When ATP and carbachol are applied sequentially at doses that give maximal exocytosis, the magnitude of the capacitance increase produced by the second secretagogue is less than or equal to that of the capacitance decrease during the recovery period. Together, these data suggest that purinergic and cholinergic agonists act on the same granule pool.  (+info)

Immunolocalization of muscarinic and VIP receptor subtypes and their role in stimulating goblet cell secretion. (7/652)

PURPOSE: To determine the subtypes of cholinergic muscarinic receptors and receptors for vasoactive intestinal peptide (VIP) present in rat conjunctival goblet cells and whether cholinergic agonists and VIP stimulate goblet cell secretion. METHODS: Immunofluorescence studies were performed using antibodies against the m1, m2, and m3 muscarinic receptor subtypes and VIP receptors 1 and 2 (VIPR1 and VIPR2). The lectin Ulex europeus agglutinin I was used to measure glycoconjugate secretion, the index of secretion, from goblet cells in an enzyme-linked lectin assay. In this assay, pieces of conjunctiva were placed on filter paper and incubated for 15 to 120 minutes, with or without increasing concentrations of the cholinergic agonist carbachol or VIP. The muscarinic antagonist atropine and the muscarinic receptor-subtype-selective antagonists pirenzepine (M1), gallamine (M2), and 4-4-diphenylacetoxy-N-(2-chloroethyl)-piperidine hydrochloride (4-DAMP mustard; M3) were incubated with carbachol to determine specificity of receptor activation. RESULTS: Immunoreactivity to M2 and M3 receptors was found on goblet cell membranes subjacent to the secretory granules. Immunoreactivity to M1 receptor was not on goblet cells but was on the stratitfied squamous cells. Immunoreactivity to VIPR2 was found on goblet cells with a localization similar to that of the M2 and M3 receptors. VIPR1 was not found on goblet cells or on the stratified squamous cells. Carbachol and VIP induced a time- and concentration-dependent stimulation of glycoconjugate secretion. Carbachol, at 10(-4) M, induced a threefold increase in glycoconjugate secretion, which was completely inhibited by atropine (10(-5) M). Carbachol-induced secretion was inhibited 54% +/- 8% by pirenzepine (10(-5) M), 69% +/- 14% by gallamine (10(-5) M), and 72% +/- 11% by 4-DAMP mustard (10(-5) M). A twofold increase in glycoconjugate secretion was obtained with VIP at 10(-8) M. CONCLUSIONS: Cholinergic agonists, through M2 and/or M3 muscarinic receptors, and VIP, through VIPR2, regulate conjunctival goblet cell secretion, suggesting that goblet cell secretion in vivo is under the control of parasympathetic nerves.  (+info)

Modulation of inhibitory synaptic potentials in the piriform cortex. (8/652)

Modulation of inhibitory synaptic potentials in the piriform cortex. Intracellular recordings from pyramidal neurons in brain slice preparations of the piriform cortex were used to test results from a computational model about the effects of cholinergic agonists on inhibitory synaptic potentials induced by stimulation of afferent fibers in layer Ia and association/intrinsic fibers in layer Ib. A simple model of piriform cortex as an associative memory was used to analyze how suppression of inhibitory synaptic transmission influenced performance of the network. Levels of suppression of excitatory synaptic transmission were set at levels determined in previous experimental work. Levels of suppression of inhibitory synaptic transmission were then systematically varied within the model. This modeling work demonstrated that suppression of inhibitory synaptic transmission in layer Ib should be stronger than suppression of inhibitory synaptic transmission in layer Ia to keep activity levels high enough for effective storage. Experimental data showed that perfusion of the cholinergic agonist carbachol caused a significant suppression of inhibitory postsynaptic potentials (IPSPs) in the pyramidal neurons that were induced by stimulation of layer Ib, with a weaker effect on IPSPs induced by stimulation of layer Ia. As previously described, carbachol also selectively suppressed excitatory postsynaptic potentials (EPSPs) elicited by intrinsic but not afferent fiber stimulation. The decrease in amplitude of IPSPs induced by layer Ib stimulation did not appear to be directly related to the decrease in EPSP amplitude induced by layer Ib stimulation. The stimulation necessary to induce neuronal firing with layer Ia stimulation was reduced in the presence of carbachol, whereas that necessary to induce neuronal firing with layer Ib stimulation was increased, despite the depolarization of resting membrane potential. Thus physiological data on cholinergic modulation of inhibitory synaptic potentials in the piriform cortex is compatible with the functional requirements determined from computational models of piriform cortex associative memory function.  (+info)

The concentrations of acetylcholine and norepinephrine and acetylcholinesterase activity in the myocardium as well as chronotropic cardiac response to exogenous mediators administered in increasing...
Bicuculline, Carbachol, Cholinergic Agonist, Gaba, Hippocampal Formation, Hippocampus, Neuron, Neurons, Population, Rats, Separated, Urethane
Carbachol- యొక్క ఉపయోగాలు, మోతాదు, దుష్ప్రభావాలు, ప్రయోజనాలు, పరస్పర చర్యలు మరియు హెచ్చరికను కనుగొనండి
A reciprocal relationship exists between agrin and acetylcholine (ACh) in controlling acetylcholine receptor (AChR) clustering at the neuromuscular junction: Agrin promotes clustering, and ACh disperses clusters. Chen et al. provide insight into how these opposing signals may allow stabilization of AChR at the neuromuscular junction by differential activity of the calcium-activated proteases calpains. Exposure of C2C12 myotubes in culture to the cholinergic agonist carbachol triggered a calcium transient, activation of calpain, and stimulation of cyclin-dependent kinase 5 (CDK5) through production of the activator p25 by cleavage of the CDK5 regulatory partner p35. (CDK5 has been previously implicated in AChR dispersal, and p35 is a known substrate for calpain.) Activation of CDK5 by carbachol was blocked by pharmacological inhibition of calpain with calpeptin, and the dispersal of AChR clusters induced by agrin was also prevented if calpain activity was blocked (pharmacologically or by RNAi). ...
The pattern of results suggests cholinergically mediated psychophysiologic pathways of emotional influence in the asthmatic process for some asthmatic children. A heuristic biopsychosocial model of these pathways is presented.
The effect that several substances may have on ANF release by atrial slices and on its tissular content was investigated. alpha- and beta-adrenergic and cholinergic agonists, vasopressin, met-enkephaline, dexamethasone and DOC, in concentration ranging from 10(-4) to 10(-8) M, were added into the in …
Depolarization-induced suppression of inhibition (DSI) is a prevailing form of endocannabinoid signalling. However, several discrepancies have arisen regarding the roles played by the two major brain endocannabinoids, 2-arachidonoylglycerol (2-AG) and anandamide, in mediating DSI. Here we studied endocannabinoid signalling in the prefrontal cortex (PFC), where several components of the endocannabinoid system have been identified, but endocannabinoid signalling remains largely unexplored. In voltage clamp recordings from mouse PFC pyramidal neurons, depolarizing steps significantly suppressed IPSCs induced by application of the cholinergic agonist carbachol. DSI in PFC neurons was abolished by extra- or intracellular application of tetrahydrolipstatin (THL), an inhibitor of the 2-AG synthesis enzyme diacylglycerol lipase (DAGL). Moreover, DSI was enhanced by inhibiting 2-AG degradation, but was unaffected by inhibiting anandamide degradation. THL, however, may affect other enzymes of lipid ...
How is carbachol-induced active sleep abbreviated? c-AS stands for carbachol-induced active sleep. c-AS is defined as carbachol-induced active sleep rarely.
Spatio-temporal patterns of CCh-induced [Ca2+]i transients. The x-y confocal Ca2+ imaging was performed at 32 Hz (A and B), 40 Hz (C), 44 Hz (D) and 30 Hz
Stoelting, R.K., Anticholinesterase Drugs and Cholinergic Agonists, in Pharmacology and Physiology in Anesthetic Practice, Lippincott-Raven Publishers, 1999, 224-237; Taylor, P. Anticholinesterase Agents, In, Goodman and Gillmans The Pharmacologial Basis of Therapeutics,(Hardman, J.G, Limbird, L.E, Molinoff, P.B., Ruddon, R.W, and Gilman, A.G.,eds) TheMcGraw-Hill Companies, Inc.,1996, pp.161-174.. ...
SHREEJI MICRO SYSTEMS INC. - Manufacturer,Supplier and Exporter of Carbachol at reasonable prices. Contact us for 100% safe Carbachol.
A Moderate Drug Interaction exists between carbachol ophthalmic and Ceron-DM Drops. View detailed information regarding this drug interaction.
In Chapter 11, we discussed the development of alpha-7-nicotinic cholinergic agonists as a novel therapeutic strategy for schizophrenia. 10.
Isopto Carbachol - Get up-to-date information on Isopto Carbachol side effects, uses, dosage, overdose, pregnancy, alcohol and more. Learn more about Isopto Carbachol
TY - JOUR. T1 - Cyclic nucleotides in muscarinic regulation of DNA and RNA polymerase activity in cultured corneal epithelial cells of the rabbit. AU - Colley, A. M.. AU - Cavanagh, Harrison D. AU - Drake, L. A.. AU - Law, M. L.. N1 - Funding Information: ACKNOWLEDGMENTS This work was supported by National Eye Institute Research Grant No. EY04604 and a Departmental grant from Research to Prevent Blindness. The authors gratefully acknowledge the technical assistance o f Mr. Neil Matthews i n photography and animal care and the administrative and clerical assistance of Mrs. Edith Barron, Mrs. Cynthia Hale, and Mrs. LaDonna Hampton.. PY - 1985. Y1 - 1985. N2 - DNA and RNA polymerase activities in the purified nuclear fraction from cultured rabbit corneal epithelial cells were assayed over a range of substrate (labeled dTTP or UTP) concentrations using calf thymus DNA as template. Effects of carbamylcholine on polymerase activities were evaluated over a range of drug concentrations including those ...
Therefore, it is also possible to modify our algorithm to study the coupling mechanisms between exocytosis and endocytosis in the future. Combinatorial microscopy. Google Scholar Employing FM fluorescence imaging, basolateral exocytosis was observed in dispersed rat pancreatic acini after supramaximal CCK or carbachol stimulation; and more remarkably, also after treatment with clinically-relevant concentrations of alcohol and putative alcohol metabolites followed by physiologic CCK or carbachol stimulation 8, 9, 28thus simulating alcoholic pancreatitis. AIP Conf. In summary, we have developed a software platform for the identification and spatiotemporal analysis of vesicle fusion events obtained by TIRF microscopy.. ...
Xerostomia is a subjective sensation of dry mouth, this is a common symptom particularly in older adults and has a variety of causes. Pilocarpine is a cholinergic agonist that non-selectively binds to muscarinic receptors in smooth muscles in the gastrointestinal, urinary and pulmonary systems and stimulates the production of secretions from the salivary and sweat [read the full story…]. ...
FLJ14154兔多克隆抗体(ab103800)可与人样本反应并经WB, ICC/IF实验严格验证并得到3个独立的用户反馈。所有产品均提供质保服务,中国75%以上现货。
TY - JOUR. T1 - Effect of Cholinergic Agonists on Muscle From Rodent Proximal and Distal Small Intestine. AU - Nowak, Thomas V.. AU - Harrington, Bonnie. PY - 1985/1/1. Y1 - 1985/1/1. N2 - Proximal and distal rat small intestine was cut into strips measuring 6.0 × 10.0 mm. Strips cut along the oral-caudal axis were called longitudinal strips, whereas those cut 90° to that axis were called circular strips. Stress in circular and longitudinal muscle strips was measured continuously as they were superf used with acetylcholine, carbamylcholine, methacholine, bethanechol, or physostigmine. Resting stress during stretch, acetylcholine-stimulated active stress, and total stress were determined. Proximal circular muscle was five times as sensitive to acetylcholine as distal circular muscle (p , 0.05); proximal longitudinal muscle was 2.8 times as sensitive to bethanechol as distal muscle (p , 0.05). Resting, active, and total stress were similar in proximal and distal muscle, but circular muscle ...
The molecular identities of the pathways that mediate K+ and Cl− effluxes in serous acinar cells are unknown. CFTR mRNA is expressed in these cells, and immunocytochemistry revealed it to be present near the apical membrane. To examine the role of CFTR in Ca2+-evoked fluid secretion, we employed cells from the cftrtm1Unc−/− mouse and we pharmacologically inhibited CFTR in WT mouse cells. The results demonstrated that mouse nasal acinar cells from both WT and cftrtm1Unc−/− mice, as well as WT cells treated with CFTRinh172, all exhibited similar rates of Cl− efflux in response to muscarinic stimulation. Isolated intact submucosal glands from CF individuals that lack functional CFTR can secrete fluid in response to cholinergic agonists (Joo et al. 2002a), and it was recently shown that intact glands in WT and cftrtm1Unc−/− mice trachea secrete fluid in response to CCh at similar rates (Ianowski et al. 2007). It has remained unclear if cholinergic-induced fluid secretion in CF glands ...
For immunofluorescence microscopy, the eyes were enucleated with the lids intact and fixed in 4% formaldehyde in phosphate-buffered saline (PBS; 145 mM NaCl, 7.3 mM Na2HPO4, and 2.7 mM NaH2PO4 [pH 7.2]), for 4 hours at 4°C. The eyes were then rinsed in 5% sucrose dissolved in PBS, placed overnight in 30% sucrose dissolved in PBS at 4°C, embedded in OCT, and frozen. Cryostat sections (6 μm) were placed on slides (Colorfrost/Plus; Fisher Scientific, Pittsburgh, PA) and kept at −20°C until use. Cultured goblet cells (CGCs) grown on glass coverslips were fixed in absolute methanol. Tissue sections and CGCs were then washed in PBS and blocked in PBS containing 1% bovine serum albumin, 4% goat serum, and 0.2% to 0.3% Triton X-100. The NT antibodies (NGF, BDNF, NT3, and NT4) were used at a dilution of 1:800. The NTr antibodies (TrkA, TrkB, TrkC, and p75) were used at a dilution of 1:200. All antibodies were diluted in PBS containing 0.3% Triton X-100 and incubated for 48 hours at 4°C. The ...
We use cookies to ensure that we give you the best experience on our website. If you click Continue we will assume that you are happy to receive all cookies and you will not see this message again. Click Find out more for information on how to change your cookie settings ...
Carbachol lowers pressure in the eye by increasing the amount of fluid that drains from the eye. Carbachol ophthalmic (for the eye) is used to reduce pressure inside the eye after cataract surgery. Carbachol ophthalmic may also be used for purposes not listed in this medication guide.
The pancreas is a mixed gland secretion (external or internal or digestive and insulin) that is in the highest part of the deep abdominal cavity behind the stomach. The pancreas is located in a transverse position with a head, body and tail. Its internal structure is clustered and each of the grains corresponds to a secretory gland acinus.
UCL Discovery is UCLs open access repository, showcasing and providing access to UCL research outputs from all UCL disciplines.
Values are means ± SE. Cholinergic responses evoked by bath application of carbachol (10 μM for 5 min) in CA3 pyramidal neurons. Boldface numbers indicate P , 0.05 for carbachol-induced effects within individual cell types (repeated-measures ANOVA with post-tests: baseline, carbachol, and wash). Asterisks indicate P , 0.01 when compared with values in wild-type neurons (one-way ANOVA with post-tests). ...
Cholinergic receptor information including symptoms, causes, diseases, symptoms, treatments, and other medical and health issues.
We studied the effects of cholinergic agonists on slow delayed-rectifier K+ current (IKs) in isolated cells from the sino-atrial node (SAN) region of guinea pig heart, using patch-clamp procedures. Carbachol (5 nM to 10 microM) inhibited IKs in guinea pig SAN cells in the absence of previous beta-adrenergic stimulation and in cells pretreated with 8-(4-chlorophenylthio)-cAMP. Neither the muscarinic antagonist atropine nor the nicotinic antagonist hexamethonium antagonized carbachol inhibition of the current. Similar results were obtained with other cholinergic agonists. Cholinergic stimulation of the muscarinic K+ current was successfully antagonized by atropine in SAN cells where inhibition of IKs persisted. Therefore, the lack of antagonist effects on inhibition of IKs cannot be attributed to either an absence of muscarinic cholinoceptors on SAN cells or a loss of antagonist activity under our experimental conditions. These data demonstrate that cholinergic agonists, including the endogenous ...
TY - JOUR. T1 - Cholinergic modulation of MEG resting-state oscillatory activity in Parkinsons disease related dementia. AU - Bosboom, J.L.W.. AU - Stoffers, D.. AU - Stam, C.J.. AU - Berendse, H.W.. AU - Wolters, E.C.. PY - 2009. Y1 - 2009. U2 - 10.1016/j.clinph.2009.03.004. DO - 10.1016/j.clinph.2009.03.004. M3 - Article. C2 - 19386543. VL - 120. SP - 910. EP - 915. JO - Clinical Neurophysiology. JF - Clinical Neurophysiology. SN - 1388-2457. IS - 5. ER - ...
Alibaba.com offers 87 emulsifiable concentrates abamectin products. About 8% of these are Insecticide. A wide variety of emulsifiable concentrates abamectin options are available to you,
IO-CHOL(Carbachol Intraocular Solution USP 0.01% w/v) Description: IO-Chol is a sterile balanced salt solution of carbachol for intracular injection. Warnings & Precautions: Do not…. ...
Our Mobile Vet Unit visits pet stores in Florida. Natural Veterinary Services FL Offers Holistic Treatments Tests for Pets. A+ Angies List 5-Star Reviews
Both drugs are agonists are nicotinic cholinergic receptors ... Kishioka S, Kiguchi N, Kobayashi Y, Saika F (2014). "Nicotine ... Fujii T, Mashimo M, Moriwaki Y, Misawa H, Ono S, Horiguchi K, Kawashima K (2017). "Expression and Function of the Cholinergic ... Nicotine increases cholinergic signaling and adrenergic signaling in colon cancer cells, thereby impeding apoptosis (programmed ... Nicotine acts as a receptor agonist at most nicotinic acetylcholine receptors (nAChRs), except at two nicotinic receptor ...
Muscarinic agonists activate muscarinic receptors while nicotinic agonists activate nicotine receptors. Both are direct-acting ... Muscarine mimics the function of the natural neurotransmitter acetylcholine in the muscarinic part of the cholinergic nervous ... Muscarinic agonists are used as drugs in treating glaucoma, postoperative ileus, congenital megacolon, urinary retention and ... Inocybe and Clitocybe contain muscarine concentrations up to 1.6%. Muscarine is a nonselective agonist of the muscarinic ...
Thus it is classified as a cholinergic agonist. It is primarily used for various ophthalmic purposes, such as for treating ... they both act on the cholinergic system, increasing cholinergic transmission), but its toxicity is much weaker and it is easier ... Use of carbachol, as well as all other muscarinic receptor agonists, is contraindicated in patients with asthma, coronary ... Carbachol elicits this REM sleep-like state via activation of postsynaptic muscarinic cholinergic receptors (mAChRs). A recent ...
Stoelting RK (1999). Anticholinesterase Drugs and Cholinergic Agonists", in Pharmacology and Physiology in Anesthetic Practice ... For a cholinergic neuron to receive another impulse, ACh must be released from the ACh receptor. This occurs only when the ... AChE is found at mainly neuromuscular junctions and in chemical synapses of the cholinergic type, where its activity serves to ... Blumenthal D, Brunton L, Goodman LS, Parker K, Gilman A, Lazo JS, Buxton I (1996). "5: Autonomic Pharmacology: Cholinergic ...
Cholinergic Agonists and Muscarinic Receptor Antagonists. St. Louis, Missouri: Elsevier. p. 82-97. ISBN 978-0-323-39307-2. OCLC ... α-receptor agonist, α2 > α1, giving negative feedback) Methyldopa (α2 agonist, giving negative feedback) Propranolol (β- ... For a cholinergic agent, the following criteria describe the structure activity relationship: Ing's Rule of 5: there should be ... A parasympathomimetic drug, sometimes called a cholinomimetic drug or cholinergic receptor stimulating agent, is a substance ...
"Reversal of pertussis toxin-induced thermal allodynia by muscarinic cholinergic agonists in mice". Neuropharmacology. 39 (12): ... Vedaclidine (INN, codenamed LY-297,802, NNC 11-1053) is an experimental analgesic drug which acts as a mixed agonist-antagonist ... May 1997). "Pharmacology of butylthio[2.2.2] (LY297802/NNC11-1053): a novel analgesic with mixed muscarinic receptor agonist ... May 1997). "Butylthio[2.2.2] (NNC 11-1053/LY297802): an orally active muscarinic agonist analgesic". The Journal of ...
Some different classes of GABAergic drugs include agonists, antagonists, modulators, reuptake inhibitors and enzymes. ... Adenosinergic Adrenergic Cannabinoidergic Cholinergic Dopaminergic Glycinergic Histaminergic Melatonergic Monoaminergic ...
Adenosinergic Adrenergic Cannabinoidergic Cholinergic Dopaminergic GABAergic Glycinergic Melatonergic Monoaminergic Opioidergic ... Examples include histamine receptor agonists and histamine receptor antagonists (or antihistamines). Subdivisions of histamine ...
Adenosinergic Adrenergic Cannabinoidergic Cholinergic Dopaminergic GABAergic Glycinergic Histaminergic Monoaminergic ... Examples include melatonin receptor agonists and melatonin receptor antagonists. ...
Adenosinergic Adrenergic Cannabinoidergic Cholinergic Dopaminergic GABAergic Histaminergic Melatonergic Monoaminergic ... Examples include glycine receptor agonists, glycine receptor antagonists, and glycine reuptake inhibitors. ...
... but there is counter-evidence suggesting some delta agonists might have weak ICSS facilitation properties. Cholinergic drugs ... Morphine, a MOR agonist, was one of the earliest studied drugs at the advent of ICSS and BSR. High potency MOR agonists like ... The effects of delta opioid receptor (DOR) agonists/antagonists on ICSS are less clear. One DOR agonist, SNC80, has been found ... GABAB receptor agonists and positive allosteric modulators have been found to result in ICSS depression and have been found to ...
Lieberman JA, Javitch JA, Moore H (August 2008). "Cholinergic agonists as novel treatments for schizophrenia: the promise of ... 1996). "PET study of the M1-agonists [11C]xanomeline and [11C]butylthio-TZTP in monkey and man". Dementia. 7 (4): 187-95. PMID ... Jakubík J, Michal P, Machová E, Dolezal V (2008). "Importance and prospects for design of selective muscarinic agonists" (PDF ... Xanomeline (LY-246,708; Lumeron, Memcor) is a muscarinic acetylcholine receptor agonist with reasonable selectivity for the M1 ...
... is a centrally acting acetylcholinesterase inhibitor and indirect cholinergic agonist (parasympathomimetic). It was the ...
Pretreatment with E1R enhanced the σ1R agonist PRE-084's stimulating effect and facilitated passive avoidance retention. It ... E1R enhances cognition and has efficacy against cholinergic dysfunction in mice without affecting locomotor activity. ...
... is a partial agonist of the 5-HT6 receptor. It enhanced recognition memory and reversed the memory deficits of ... The mechanism of memory enhancement is due to a combined modulation of cholinergic and glutamatergic neurotransmission. E-6837 ... Kendall, I. (February 2011). "E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of ... cholinergic and glutamatergic neurotransmission in the rat". Psychopharmacology. 213 (2-3): 413-30. doi:10.1007/s00213-010-1854 ...
Amongst the common drugs of abuse, nicotine is one of the strongest agonists at the nicotinic cholinergic synapse. Nicotine, ...
Hartzell HC, Titus L (Feb 1982). "Effects of cholinergic and adrenergic agonists on phosphorylation of a 165,000-dalton ...
Examples include excitatory amino acid receptor agonists, excitatory amino acid receptor antagonists, and excitatory amino acid ... Adenosinergic Adrenergic Cannabinoidergic Cholinergic Dopaminergic GABAergic GHBergic Glycinergic Histaminergic Melatonergic ...
Muscarinic agonist Muscarinic antagonist Nicotinic acetylcholine receptor Nicotinic agonist Nicotinic antagonist Eglen RM (July ... Very few parts of the sympathetic system use cholinergic receptors. In sweat glands the receptors are of the muscarinic type. ... Also, only when bound with an agonist, those G proteins normally sensitive to PTX also become susceptible to CTX. The various G ... Possible bronchospasm may result if stimulated by muscarinic agonists Location of M5 receptors is not well known. Like the M1 ...
... a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder". Am J Psychiatry. 156 (12): ... Potter A, Corwin J, Lang J, Piasecki M, Lenox R, Newhouse PA (March 1999). "Acute effects of the selective cholinergic channel ... It acts as an agonist at neural nicotinic acetylcholine receptors, subtype-selective binding with high affinity to the α4β2, α7 ... Wilens TE, Decker MW (October 2007). "Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity ...
... is a β1 and β2 adrenoreceptor agonist and has almost no activity on alpha adrenergic receptors. Its agonist ... Mehta, Akul (January 27, 2011). "Notes - Medicinal Chemistry of the Peripheral Nervous System - Adrenergics and Cholinergic". ... It is a non-selective β adrenoceptor agonist that is the isopropylamine analog of epinephrine (adrenaline). It is used to treat ... Jalba, MS (2008). "Three generations of ongoing controversies concerning the use of short acting beta-agonist therapy in asthma ...
Adrenergic Cannabinoidergic Cholinergic Dopaminergic GABAergic Glycinergic Histaminergic Melatonergic Monoaminergic Opioidergic ... Examples include adenosine receptor agonists, adenosine receptor antagonists (such as caffeine), and adenosine reuptake ...
As all cholinergic fibers contain high concentrations of ACh and AChE at their terminals, inhibition of AChE can impair their ... This phenomenon is caused by the excess of agonists (ACh) within the synapse, ultimately leading to a down-regulation of ... Cholinergic nerves play an important role in the normal function of the central nervous, endocrine, neuromuscular, ... When patients are resistant to atropine, the patients can be treated with low doses of anisodamine, a cholinergic and alpha-1 ...
Like the tropanes, it acts on cholinergic neurons, but with the opposite effect (it is an agonist as opposed to an antagonist ... They can reverse cholinergic poisoning, which can be caused by overexposure to organophosphate insecticides and chemical ...
The symptoms of nicotine poisoning are caused by effects at nicotinic cholinergic receptors. Nicotine is an agonist at ... Nicotine is specific for nicotinic cholinergic receptors only and has some, but not all of the symptoms of organophosphate ... excessive stimulation of all types of cholinergic neurons, and a wide range of symptoms. ...
"In vivo muscarinic cholinergic mediated effects of Lu 25-109, a M1 agonist and M2/M3 antagonist in vitro". Psychopharmacology. ... Alvameline (Lu 25-109) is a M1 receptor agonist and M2/M3 receptor antagonist that was under investigation for the treatment of ... A quite different tack involves developing compounds that have cholinergic activity in their own right. The tetrazole ... yielding the muscarinic agonist alvameline (8). Milameline Sabcomeline Tazomeline Xanomeline Sánchez C, Arnt J, Didriksen M, ...
Karczmar demonstrated that cholinergic agonists counteract the behavior exhibited in animal models of schizophrenia; on this ... Cholinergic mechanisms, schizophrenia, and neuropsychiatric adaptive dysfunctions. In: Central Cholinergic Mechanisms and ... Cholinergic control of hypokinesia. Prog. Clin. Biol. Res. 39: 374. Karczmar, A. G. and Long, J. P. 1958. Relationship between ... He is widely recognized for his experimental research, almost all of which is devoted to the cholinergic system, both central ...
One specific drug candidate is BB14, which is a nerve growth factor-like peptide that acts as a TrkA agonist. BB14 was shown to ... For example, a few studies have used nerve growth factors to regain some cholinergic function in patients with Alzheimer's. ...
Injection of a cholinergic agonist (e.g. carbachol), into the pontine tegmentum produces a state of REM sleep in cats. PET ... Woolf, NJ; Butcher, LL (2011). "Cholinergic systems mediate action from movement to higher consciousness". Behavioural Brain ... The pontine tegmentum contains two predominately cholinergic nuclei, the pedunculopontine nucleus (PPN) and the laterodorsal ... the mesopontine cholinergic system comprising the pedunculopontine nucleus and the laterodorsal tegmental nucleus, and in the ...
Agonists (abridged; see here for more): 2-AG. *2-AGE (noladin ether) ...
In addition to its actions as an acetylcholinesterase inhibitor, donepezil has been found to act as a potent agonist of the σ1 ... Kása P, Rakonczay Z, Gulya K (August 1997). "The cholinergic system in Alzheimer's disease". Progress in Neurobiology. 52 (6): ... Just the severity of the loss of cholinergic neurons of the central nervous system (CNS) has been found to correlate with the ... This increases acetylcholine concentrations at cholinergic synapses.[1] The precise mechanism of action of donepezil in ...
... and cholinergic agonists.[5]. Miscellaneous[edit]. *In people with a past history of spinal cord injuries *Autonomic ...
Unë gjithashtu gjeti se acetilkolinės dhe agjentë të tjerë cholinergic inhibited përgatitjet adenylyl cyclase, përshkrimin e ... l epinephrine dhe-l norepinephrina me ndalim nga dichloroisoproterenol dhe dështimi i alfa blockers dhe agonist të kenë efekte ...
For receptors, these activities include agonist, antagonist, inverse agonist, or modulator. Enzyme target mechanisms include ... Conversely not all PPAR agonists are fibrates, not all triglyceride lowering agents are PPAR agonists, and not all drugs that ... PPAR agonist), mode of action (reducing blood triglycerides), and are used to prevent and to treat the same disease ( ...
Glycine receptor agonists. *Nervous system drug stubs. Hidden categories: *ECHA InfoCard ID from Wikidata ...
Antidepressants affect variable neuronal receptors like muscarinic-cholinergic, α1- and α2-adrenergic, and H1-histaminergic ... Alpha-2 agonists (e.g., clonidine, dexmedetomidine, guanfacine). *Beta blockers (e.g., propranolol) ...
Entrez Gene: CHRM3 cholinergic receptor, muscarinic 3".. *^ Keith Parker; Laurence Brunton; Goodman, Louis Sanford; Lazo, John ... Szekeres PG, Koenig JA, Edwardson JM (1998). „The relationship between agonist intrinsic activity and the rate of endocytosis ... Gutkind JS, Novotny EA, Brann MR, Robbins KC (1991). „Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes ...
Mixed opioid agonist-antagonist, partial agonist at mu-1 receptor; cholinergic actions exist.. IM, IV, PO.. Bioavailability = ... Full agonist at kappa opioid receptors, partial agonist/antagonist at the mu opioid receptors.[39]. IM, IV, SC.. Protein ... Partial agonist at the mu opioid receptor; agonist at delta opioid receptor; antagonist at kappa opioid receptor.. Sublingual, ... Kappa opioid receptor agonist; mu opioid receptor antagonist/partial agonist.. IM, IV, SC.. Bioavailability = 60-70%; protein ...
Kendall, I. (2011). „E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and ... E-6801 je parcijalni agonist 5-HT6 receptora.[1] On poboljšava memoriju prepoznavanja i poništava memorijski deficit uzrokovan ...
Activity of PT cholinergic neurons (REM-on cells) promotes REM sleep. During waking, REM-on cells are inhibited by a subset of ... A search for small-molecule agonists at orexin receptors is underway and could lead to a treatment for narcolepsy.. ... They excite the REM-off monoaminergic neurons during wakefulness and the PT cholinergic neurons during REM sleep. They are ... and cholinergic pedunculopontine nucleus and laterodorsal tegmental nucleus.[2][8] The histaminergic, dopaminergic, ...
The Cholinergic Hypothesis of Alzheimer's Disease: a Review of Progress. Journal of Neurology, Neurosurgery, and Psychiatry. ... and GLP-1 Receptor Agonists. Annals of the New York Academy of Sciences. 2004;1035:290-315. doi:10.1196/annals.1332.018. PMID ... Martorana, Alessandro; Esposito, Zaira; Koch, Giacomo (2010-08-01). "Beyond the cholinergic hypothesis: do current drugs work ...
Agonist: Inverzni agonist • Ireverzibilni agonist • Parcijalni agonist • Superagonist • Fiziološki agonist. Antagonist: ... "Actions of Snake Neurotoxins on an Insect Nicotinic Cholinergic Synapse." Invertebrate Neuroscience, 7 (3): 173-78. ...
Chiodera P, Volpi R, Capretti L, Caffarri G, Magotti MG, Coiro V (April 1996). "Different effects of the serotonergic agonists ... Uvnäs-Moberg K, Hillegaart V, Alster P, Ahlenius S (1996). "Effects of 5-HT agonists, selective for different receptor subtypes ... perhaps the vasopressin V1A receptor where oxytocin is known to weakly bind as an agonist.[84][85] ... vasopressin and the non-peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in rats". British Journal of ...
Desensitisation of nicotinic ACh receptors: shaping cholinergic signaling". Trends Neurosci. 28 (7): 371-378. PMID 15979501. ... Ko se agonist veže na vezavno mesto, se vse podenote konformacijsko spremenijo in ionski kanalček se odpre.[11] Pri tem nastane ... dokler agonist ostaja vezan na vezavno mesto, kar običajno traja okoli 1 milisekundo.[3] V redkih primerih pa se lahko kanalček ... deluje kot močan in selektiven agonist na živčne nikotinske receptorje) ... Poznani so tudi antagonisti, na primer ...
... cholinergic brainstem and the spinal cord.[23][25] It was found that NGF-knockout mice had losses of a majority of their dorsal ... have been identified as small-molecule agonists of the TrkA and p75NTR with high affinity (around 5 nM), and hence as so-called ...
Agonists: 25H/NB series (e.g., 25I-NBF, 25I-NBMD, 25I-NBOH, 25I-NBOMe, 25B-NBOMe, 25C-NBOMe, 25TFM-NBOMe, 2CBCB-NBOMe, 25CN- ... Stanton T, Bolden-Watson C, Cusack B, Richelson E (1993). "Antagonism of the five cloned human muscarinic cholinergic receptors ... Agonists: 2Cs (e.g., 2C-B, 2C-E, 2C-I, 2C-T-2, 2C-T-7, 2C-T-21) ... Agonists: Ergolines (e.g., 2-Br-LSD (BOL-148), ergotamine, LSD) ... Agonists: Ergolines (e.g., dihydroergocryptine, dihydroergotamine, ergotamine, lisuride, LSD, mesulergine, metergoline, ...
Francis PT, Palmer AM, Snape M, Wilcock GK (Februari 1999). "The cholinergic hypothesis of Alzheimer's disease: a review of ... and GLP-1 receptor agonists". Ann. N. Y. Acad. Sci. 1035: 290-315. doi:10.1196/annals.1332.018 . PMID 15681814 . ...
a b c d e f g h i j k l m n ñ o p q r s t u pharmamotion.com , Serotonin (5-HT): receptors, agonists and antagonists By Flavio ... Blockade of 5-HT 1B receptors facilitates contextual aversive learning in mice by disinhibition of cholinergic and ... a b Meneses A, Hong E (1997). «Effects of 5-HT4 receptor agonists and antagonists in learning». Pharmacol Biochem Behav 56 (3 ... a b Dietz BM, Mahady GB, Pauli GF, Farnsworth NR (2005). «Valerian extract and valerenic acid are partial agonists of the 5- ...
A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys. Journal of Pharmacology and ... Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition. ... Central nicotinic receptor agonists ABT-418, ABT-089, and (−)-nicotine reduce distractibility in adult monkeys. ... ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults ...
Stoelting R (1999). Anticholinesterase Drugs and Cholinergic Agonists", in Pharmacology and Physiology in Anesthetic Practice. ... Shaked I, Meerson A, Wolf Y, Avni R, Greenberg D, Gilboa-Geffen A, Soreq H (2009). "MicroRNA-132 potentiates cholinergic anti- ... Blumenthal D, Brunton L, Goodman LS, Parker K, Gilman A, Lazo JS, Buxton I (1996). "5: Autonomic Pharmacology: Cholinergic ... Cholinergic Drugs". The Pharmacologial Basis of Therapeutics. THe McGraw-Hill Companies. str. 161-174. ISBN 978-0-07-146804-6. ...
This leads to the inhibition of cholinergic, noradrenergic and serotonergic activity in these areas. Noradrenergic projections ... as demonstrated by increased time in NREM sleep in response to microinjections of GABA agonists into the median preoptic area ...
Orthosteric Agonist Muscimol,[59] GABA,[59] gaboxadol (THIP),[59] isoguvacine, progabide, piperidine-4-sulfonic acid (partial ... agonist) Positive allosteric modulators Barbiturates,[60] benzodiazepines,[61] neuroactive steroids,[62] niacin/niacinamide,[63 ... "STUDY OF GABAERGIC AGONISTS" (PDF). Deccan Journal of Pharmacology. 1 (2): 56-69. Archived from the original (PDF) on 2013-10- ...
... is a required co-agonist along with glutamate for NMDA receptors. In contrast to the inhibitory role of glycine in the ...
2007). "Cholinergic precursors in the treatment of cognitive impairment of vascular origin: Ineffective approaches or need for ... Agonists. (and PAMs). *5-HIAA. *A-84,543. *A-366,833. *A-582,941. *A-867,744 ...
... a shorter-acting cholinergic antagonist) or phenylephrine (an α-adrenergic agonist) is preferred as an aid to ophthalmic ... Also indirect D2 agonists, such as dopamine reuptake inhibitors (cocaine, methylphenidate), releasing agents (amphetamine, ...
Cholinergic hypothesis. The oldest, on which most currently available drug therapies are based, is the cholinergic hypothesis,[ ... and GLP-1 receptor agonists". Annals of the New York Academy of Sciences. 1035: 290-315. doi:10.1196/annals.1332.018. PMID ... Reduction in the activity of the cholinergic neurons is a well-known feature of Alzheimer's disease.[172] Acetylcholinesterase ... The cholinergic hypothesis has not maintained widespread support, largely because medications intended to treat acetylcholine ...
Francis PT, Palmer AM, Snape M, Wilcock GK (1999). «The Cholinergic Hypothesis of Alzheimer's Disease: a Review of Progress». ... and GLP-1 Receptor Agonists». Annals of the New York Academy of Sciences. 1035: 290-315. PMID 15681814. doi:10.1196/annals. ...
Cholinergic neurons are capable of producing ACh. An example of a central cholinergic area is the nucleus basalis of Meynert in ... Acetylcholine receptor agonists and antagonists can either have an effect directly on the receptors or exert their effects ... Damage to the cholinergic (acetylcholine-producing) system in the brain has been shown to be associated with the memory ... Agonists increase the level of receptor activation, antagonists reduce it.. Acetylcholine itself does not have therapeutic ...
Cholinergic Agonists. Class Summary. Excessive parasympathetic suppression appears to be involved in the genesis of intestinal ... Drugs used in the management of intestinal motility disorders include cholinergic agonists, prokinetic agents, opioid ... Tegaserod is a serotonin type 4 receptor partial agonist with no affinity for 5-HT3 receptors. It may trigger peristaltic ... Cholinergic agents may allow early resolution of pseudo-obstruction and obviate surgery. ...
Cholinergic Agonists. Class Summary. Cholinergic agonists produce symptomatic improvement in strength, autonomic symptoms, or ... resulting in ACh accumulation at synapses and increasing stimulation of cholinergic receptors at myoneural junction. ... of Lambert-Eaton myasthenic syndrome synaptic impairment by the combined use of a K+ channel blocker and a Ca2+ channel agonist ...
Any agent that is capable of activating cholinergic receptors (nicotinic and muscarinic) or of enhancing or prolonging the ... Cholinergic Agonists. Known as: Cholinergic Agonist, Agonists, Cholinergic, Acetylcholine Agonists (More). Any agent that is ... Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. *Hong Wang, Hong Liao, +9 authors L. ... Cholinergic agonists attenuate renal ischemia-reperfusion injury in rats.. *Michael M Yeboah, Xiangying Xue, +4 authors ...
Characterization of buccal motor programs elicited by a cholinergic agonist applied to the cerebral ganglion of Aplysia ... Applying the non-hydrolyzable cholinergic agonist carbachol (CCh) to the cerebral ganglion of Aplysia elicits sustained, ...
Evidence for presynaptic inhibition of the olfactory commissural pathway by cholinergic agonists and stimulation of the nucleus ... Evidence for presynaptic inhibition of the olfactory commissural pathway by cholinergic agonists and stimulation of the nucleus ... Evidence for presynaptic inhibition of the olfactory commissural pathway by cholinergic agonists and stimulation of the nucleus ... Evidence for presynaptic inhibition of the olfactory commissural pathway by cholinergic agonists and stimulation of the nucleus ...
Pharmacological Characterization of SIB-1765F: A Novel Cholinergic Ion Channel Agonist. Aida I. Sacaan, Richard T. Reid, Emily ... Pharmacological Characterization of SIB-1765F: A Novel Cholinergic Ion Channel Agonist. Aida I. Sacaan, Richard T. Reid, Emily ... Pharmacological Characterization of SIB-1765F: A Novel Cholinergic Ion Channel Agonist. Aida I. Sacaan, Richard T. Reid, Emily ... Pharmacological Characterization of SIB-1765F: A Novel Cholinergic Ion Channel Agonist Message Subject (Your Name) has ...
In conclusion, we demonstrate that canonical nicotinic agonists and phosphocholine elicit metabotropic nAChR activity in ... Furthermore, we identified phosphocholine (PC) and dipalmitoylphosphatidylcholine (DPPC) as novel nicotinic agonists that ... Furthermore, we identified phosphocholine and dipalmitoylphosphatidylcholine as novel nicotinic agonists that elicit ... function as nAChR agonists. In peripheral blood mononuclear cells from nAChR gene-deficient mice, we demonstrated that ...
Study Cholinergic agonists and antagonists flashcards from Leslie Rea ... Cholinergic agonists and antagonists Flashcards Preview Pharm , Cholinergic agonists and antagonists , Flashcards ... 1. muscarine → muscarinic agonist. 2. Arecoline → muscarinic and nicotinic agonist. 3. Pilocarpine → mainly muscarinic agonist ... 1. What is the difference b/t a direct-acting and indirect-acting cholinergic agonist? ...
... is a potent and selective M1 agonist that crosses the blood... ... an M1-Specific Cholinergic Agonist, in Patients with ... Cholinergic Agonist Healthy Elderly Subject Orthostatic Blood Pressure Moderate Nausea Moderate Diarrhea These keywords were ... an M1-Specific Cholinergic Agonist, in Patients with Alzheimers Disease. In: Hanin I., Yoshida M., Fisher A. (eds) Alzheimers ... Clinical trials of other cholinergic compounds have shown that the AD patient population frequently tolerates drugs quite ...
The methods comprise treating the macrophage with a cholinergic agonist in an amount sufficient to decrease the amount of the ... Methods for determining whether a compound is a cholinergic agonist reactive with an α7 nicotinic receptor are also provided. ... These methods comprise determining whether the compound reduces the ability of a cholinergic agonist to inhibit the release of ... The methods comprise treating the patient with a cholinergic agonist in an amount sufficient to inhibit the inflammatory ...
A contracting muscle that is resisted or... Explanation of cholinergic agonist (2) ... Find out information about cholinergic agonist (2). A chemical substance that can combine with a cell receptor and cause a ... Related to cholinergic agonist (2): Adrenergic agonist. agonist. [′ag·ə‚nist] (biochemistry) A chemical substance that can ... agonist. (redirected from cholinergic agonist (2)). Also found in: Dictionary, Thesaurus, Medical. ...
Cholinergic agents increase cholinergic transmission and therefore produce all the similar effects shown by parasympathetic ... Cholinergic agonists - IntroductionNicotinic receptorsMuscarinic receptorsClassificationDirectly acting cholinergic agents ... Cholinergic agonists - IntroductionNicotinic receptorsMuscarinic receptorsClassificationDirectly acting cholinergic agents ... Before going to directly discuss about these drugs, lets have few details about cholinergic receptors and how they work. ...
Pemphigus Vulgaris Acantholysis Ameliorated by Cholinergic Agonists. Vu Thuong Nguyen, PhD; Juan Arredondo, PhD; Alexander I. ... Neonatal athymic nude mice were used to test direct antiacantholytic effects of cholinergic agonists. At the third day of life ... We have previously reported that PV IgG-induced acantholysis can be treated in culture with cholinergic agonists.7 ... Cholinergic agonists stimulated expressionof E-cadherin and abolished phosphorylation of E-cadherin and plakoglobinin ...
The cholinergic agonist compositions can be prepared with carriers that can protect the cholinergic agonist against rapid ... In certain embodiments, the cholinergic agonist is a muscarinic receptor agonist. [0037] The term "muscarinic receptor agonist ... where the cholinergic agonist is administered as a suppository. [0011] In various embodiments, the cholinergic agonist can be ... wherein the cholinergic agonist is administered intravaginally. 48. The method of claim 47, wherein the cholinergic agonist is ...
Activated Charcoal, Polyethylene Glycol, Cholinergic Agonists, and Plasmapheresis. No data exist on the effectiveness of ... Cholinergic agonists such as guanidine and 3,4-diaminopuridine have been used in attempts to stimulate acetylcholine release ... and is transported to peripheral cholinergic nerve terminals, including neuromuscular junctions, postganglionic parasympathetic ...
Muscarinic agonists We have already listed some non-selective muscarinic agonists. There are a few muscarinic agonists that are ... Other nicotinic agonists are lobeline (from the Lobelia plant), and dimethylphenylpiperazinium (DMPP), both of which favour ... ACh has similar agonist effects at both muscarinic and nicotinic receptors, but there are several other agents that favour ... The prototype agonist is muscarine, derived from the poisonous fly agaric, Amanita muscaria. ...
The expected effect of a muscarinic agonist is vasodepression, but administration of pilocarpine may produce hypertension after ...
Carbachol is a potent cholinergic (parasympathomimetic) agent which produces constriction of the iris and ciliary body ... Carbachol elicits this REM sleep-like state via activation of postsynaptic muscarinic cholinergic receptors (mAChRs). ...
The characteristics of cholinergic transients evoked by the direct α7 agonist substantiate the conclusion that the duration of ... Cholinergic transients evoked by prefrontal pressure ejections of the α7 nAChR agonist A-582941 and role of dopaminergic ... C shows examples of cholinergic transients evoked by α7 nAChR agonist A-582941 (2 nmol) in a sham-operated control animal and ... 1999) A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit ...
... or no cholinergic agonist, which demonstrate that cholinergic agonists do not reduce LPS-stimulated TNF mRNA levels in ... 0040] As used herein, a cholinergic agonist is a compound that binds to cells expressing cholinergic receptor activity. The ... cholinergic agonist. [0099] The neural-immune interaction described here, which we term the "cholinergic anti-inflammatory ... Cholinergic Agonists Inhibit Release of Proinflammatory Cytokines from Macrophages [0064] 1. Materials and Methods [0065] Human ...
The Anti-Inflammatory Potential of Selective Cholinergic Agonists. Ulloa, Luis Ulloa, Luis Less ... Effects of the α7 Nicotinic Acetylcholine Receptor Agonist Gts-21 on the Innate Immune Response in Humans. Kox, Matthijs; Pompe ...
The revised and updated 2011 edition of the most accessible, comprehensive and affordable guide to prescription and nonprescription drugs. The classic guide to all major prescription and nonprescription drugs, featuring revised, up-to date FDA information and an A-Z list of medical conditions and their commonly used drugs for easy reference. It includes coverage of dosage and length of time before the drug takes effect, side effects, special precautions, interactions with other food and drugs, standards for use by different age groups, and much more. It also features a generic and brand name directory, a comprehensive glossary, and complete index by generic, brand, and class name.
Cholinergic Agonists * Cholinergic Antagonists * Adrenergic Agonists * Adrenergic Antagonists See Moodle for Web-based ...
... cholinergic; cholinergic agonist; cholinesterase deactivator; coccidiostat; cognition adjuvant; cognition enhancer; depressant ... LNRII agonist; liver disorder treatment; luteolysin; memory adjuvant; mental performance enhancer; mood regulator; mucolytic; ...
1, January 1992 Copyright Association for Research in Vision and Ophthalmology Effects of Cholinergic and Adrenergic Agonists ... The a 2 agonist clonidine decreased basal camp synthesis and reduced the effect of isoproterenol. The cholinergic agonist ... Effects of Cholinergic and Adrenergic Agonists on Adenylate Cyclase Activity of Retinal Microvascular Pericytes in Culture. ... forskolin with or without agonists, agonists in different concentration, or agonists with or without antagonists). On each day ...
Nicotinic Agonists * Protein Binding / drug effects * Protein Subunits / chemistry * Protein Subunits / metabolism* ... Nicotinic cholinergic receptors in the rat cerebellum: multiple heteromeric subtypes J Neurosci. 2005 Oct 5;25(40):9258-65. doi ...
Sturaitis, M. K., Moore, L. E., Kirsch, J. R., & McPherson, R. W. (1994). A cholinergic agonist induces cerebral hyperemia in ... Sturaitis, M. K. ; Moore, L. E. ; Kirsch, J. R. ; McPherson, R. W. / A cholinergic agonist induces cerebral hyperemia in ... A cholinergic agonist induces cerebral hyperemia in isoflurane- but not pentobarbital-anesthetized dogs. / Sturaitis, M. K.; ... A cholinergic agonist induces cerebral hyperemia in isoflurane- but not pentobarbital-anesthetized dogs. Anesthesia and ...
Dopamine Agonists. *Cholinergic Agonists and Antagonists. *Antihypertensives. *Antihistamines. *Cancer Therapies. *Estrogens. * ...
  • Tegaserod is a serotonin type 4 receptor partial agonist with no affinity for 5-HT3 receptors. (medscape.com)
  • Pyridostigmine blocks ACh hydrolysis by cholinesterase, resulting in ACh accumulation at synapses and increasing stimulation of cholinergic receptors at myoneural junction. (medscape.com)
  • Any agent that is capable of activating cholinergic receptors (nicotinic and muscarinic) or of enhancing or prolonging the actions of acetylcholine. (semanticscholar.org)
  • Nicotine, the prototypical agonist for neuronal nicotinic acetylcholine receptors (NAChR), nonselectively activates NAChR limiting its use in elucidating the function of NAChR subtypes. (aspetjournals.org)
  • Recently, we discovered a cholinergic mechanism that inhibits the adenosine triphosphate (ATP)-dependent release of interleukin-1β (IL-1β) by human monocytes via nicotinic acetylcholine receptors (nAChRs) composed of α7, α9 and/or α10 subunits. (frontiersin.org)
  • Before going to directly discuss about these drugs, let's have few details about cholinergic receptors and how they work. (egpat.com)
  • Here is a video on different types of cholinergic receptors and their drug targets. (egpat.com)
  • Patients develop autoantibodies to adhesion molecules mediating intercellular adhesion and to keratinocyte cholinergic receptors regulatingcell adhesion. (jamanetwork.com)
  • Note that the effects of cholinergic agents are complex, not only because of the existence of nicotinic and muscarinic receptors (and subclasses of these) but also because of the presynaptic and postsynaptic locations of such receptors. (anaesthetist.com)
  • Epibatidine (from the Dendrobatid poison dart frog Epipedobates tricolor ) is a potent agonist at nicotinic receptors. (anaesthetist.com)
  • Nicotine and, more robustly, selective agonists at α4β2* nicotinic acetylcholine receptors (nAChRs) enhance cue detection and attentional performance by augmenting prefrontal cholinergic activity. (jneurosci.org)
  • Carbachol elicits this REM sleep-like state via activation of postsynaptic muscarinic cholinergic receptors (mAChRs). (pharmacycode.com)
  • Other possible pharmacological strategies include increasing acetylcholine release with 5-HT 4 agonists or directly stimulating cholinergic receptors with muscarinic and nicotinic agonists. (nih.gov)
  • These results suggest that pericytes have functional adrenergic and cholinergic receptors, and they might respond to autonomic vasoactive substances present in vivo. (healthdocbox.com)
  • Harden, TK, Petch Lee, LA & Traynelis, SF 1985, ' Agonist-induced change in the membrane form of muscarinic cholinergic receptors (MR) in astrocytoma cells ', Federation Proceedings , vol. 44, no. 5. (elsevier.com)
  • Here, we describe a role for central muscarinic acetylcholine receptors in the activation of the cholinergic antiinflammatory pathway. (pnas.org)
  • Blockade of peripheral muscarinic receptors did not abolish antiinflammatory signaling through the vagus nerve, indicating that peripheral muscarinic receptors on immune cells are not required for the cytokine-regulating activities of the cholinergic antiinflammatory pathway. (pnas.org)
  • The role of central muscarinic receptors in activating the cholinergic antiinflammatory pathway is of interest for the use of centrally acting muscarinic cholinergic enhancers as antiinflammatory agents. (pnas.org)
  • Although the vagus nerve is a "classical" cholinergic regulator of visceral functions in which peripheral muscarinic acetylcholine receptors have a major mediating role, the vagus-nerve cytokine-inhibiting activity (which is termed "the cholinergic antiinflammatory pathway") requires signaling through nicotinic α 7 subunit-containing receptors ( 4 , 5 ). (pnas.org)
  • In contrast, peripheral muscarinic receptors do not have a major role in mediating the inflammatory response to endotoxin and its inhibition by the cholinergic antiinflammatory pathway. (pnas.org)
  • To study the role of central muscarinic receptors in the inhibition of serum TNF, we administered intracerebroventricularly (i.c.v.) the prototype muscarinic receptor agonist muscarine (0.5-500 ng/kg) before endotoxin exposure. (pnas.org)
  • Muscarine dose-dependently inhibited serum TNF ( Fig. 1 A ). Postsynaptically located M1 subtype muscarinic receptors have an important role in the processing of cholinergic neurotransmission in the brain ( 11 , 12 ). (pnas.org)
  • We explored the possibility that APP processing is regulated by activation of endogenous cell-surface neurotransmitter receptors by stimulating C6, PC12 and neuroblastoma cells with the cholinergic agonist carbachol. (elsevier.com)
  • These results suggest that the decrease in intracellular APP seen after stimulation by carbachol has some specificity and that APP processing may be regulated by stimulation of cholinergic receptors on the surface of cells. (elsevier.com)
  • [3] Muscarinic agonists activate muscarinic receptors while nicotinic agonists activate nicotine receptors. (wikipedia.org)
  • they produce their effects by binding to and activating cholinergic receptors. (wikipedia.org)
  • Partial agonist and weak antagonist at mu receptors. (brainscape.com)
  • Head skin stimulation activates a cholinergic pathway which then opens G protein-coupled inward-rectifying potassium channels (GIRKs) via postsynaptic M muscarinic receptors to inhibit brainstem neurons critical for the initiation and maintenance of swimming for up to minutes and can explain many features commonly observed immediately after concussion. (bireme.br)
  • Nicotine acts as a receptor agonist at most nicotinic acetylcholine receptors (nAChRs), except at two nicotinic receptor subunits (nAChRα9 and nAChRα10) where it acts as a receptor antagonist. (wikipedia.org)
  • In Alzheimer disease (AD), amyloid formation may decrease the ability of these receptors to transmit signals, leading to decreased cholinergic activity. (wikipedia.org)
  • The targets for muscarinic agonists are the muscarinic receptors: M1, M2, M3, M4 and M5. (wikipedia.org)
  • A partial agonist produces less than the maximum effect even if given in a concentration sufficient to bind with all available receptors. (thefreedictionary.com)
  • Adenosine receptors: development of selective agonists and antagonists. (biomedsearch.com)
  • It is an agonist at both muscarinic and nicotinic acetylcholine receptors. (curehunter.com)
  • Drugs used in the management of intestinal motility disorders include cholinergic agonists, prokinetic agents, opioid antagonists, antidiarrheals, and antibiotics. (medscape.com)
  • Materials and Methods Agonists and Antagonists Prazosin was obtained from Pfizer (Brooklyn, NY). (healthdocbox.com)
  • Muscarinic Agonists and Antagonists - Some Therapeutic Applications. (routledge.com)
  • This has lead to a number of significant advances including 5HT 3 antagonists for the treatment of functional diarrhoea, 5HT 4 agonists for the treatment of constipation and 5HT 1 agonists for the treatment of impaired fundal relaxation. (wiley.com)
  • As more specific agonists and antagonists have become available more discriminating studies have become possible to define these many separate and sometimes conflicting responses. (wiley.com)
  • Pilocarpine is a tertiary amine that is stable to hydrolysis by acetylcholinesterase and acts as a partial muscarinic agonist. (brainscape.com)
  • Methods of treating disorders with cholinergic agonists for example, muscarinic receptor agonists such as pilocarpine and cevimeline are provided. (patentsencyclopedia.com)
  • 50. The method of claim 49, wherein the muscarinic receptor agonist is pilocarpine or a pharmaceutically acceptable salt thereof. (patentsencyclopedia.com)
  • The expected effect of a muscarinic agonist is vasodepression, but administration of pilocarpine may produce hypertension after a brief episode of hypotension. (pharmacycode.com)
  • Salagen ® Tablets contain pilocarpine hydrochloride, a cholinergic agonist for oral use. (drugs.com)
  • Pilocarpine is a cholinergic parasympathomimetic agent exerting a broad spectrum of pharmacologic effects with predominant muscarinic action. (drugs.com)
  • Pilocarpine is in a class of medications called cholinergic agonists. (medlineplus.gov)
  • In the form of pilocarpine, muscarinic receptor agonists have been used medically for a short time. (wikipedia.org)
  • Pilocarpine is a drug that acts as a muscarinic receptor agonist that is used to treat glaucoma. (wikipedia.org)
  • Pilocarpine, a cholinergic agonist, significantly reduced the high levels of serum prolactin in estrogen-primed male rats and in female rats on the late afternoon of proestrus. (semanticscholar.org)
  • The decline in desensitization may be due to developmental changes in the atropine-sensitive cholinergic receptor and/or in the potassium conductance activatd by the drug-receptor interaction. (aspetjournals.org)
  • In addition, intra-vaginal administration of cholinergic agonists such as muscarinic receptor agonists to patients suffering from interstitial cystitis, vaginal dryness, and sexual dysfunction associated with vaginal dryness is also provided. (patentsencyclopedia.com)
  • 48. The method of claim 47, wherein the cholinergic agonist is a muscarinic receptor agonist. (patentsencyclopedia.com)
  • The nicotine patch which provides a sustained low dose of nicotine is a nicotine receptor agonist. (clinicaltrials.gov)
  • Lorcaserin, a serotonin 5-hydroxytryptamine receptor 2C (5-HT2C) agonist, is a drug that is FDA-approved for weight loss, and has also recently been shown to be efficacious for smoking cessation. (clinicaltrials.gov)
  • Central muscarinic cholinergic activation by muscarine, the M1 receptor agonist McN-A-343, and the M2 receptor antagonist methoctramine inhibited serum TNF levels significantly during endotoxemia. (pnas.org)
  • Our results indicate that central cholinergic activation by selective muscarinic receptor ligands significantly inhibits systemic TNF in endotoxemic rats and activates the efferent vagus-nerve activity. (pnas.org)
  • These findings identify a pivotal role for central muscarinic cholinergic activation in the inhibition of the systemic inflammatory response during endotoxemia and indicate that the cholinergic antiinflammatory pathway represents a peripheral muscarinic-receptor-independent cholinergic function of the vagus nerve. (pnas.org)
  • There is evidence that genetic variations in the M3 receptor are associated with early-onset type 2 diabetes and the acute insulin response in Pima Indians ( 17 ), but few studies have investigated cholinergic mechanisms in human islets ( 16 , 18 - 20 ). (diabetesjournals.org)
  • Muscarine is a nonselective agonist of the muscarinic acetylcholine receptor . (wikipedia.org)
  • A muscarinic agonist is an agent that activates the activity of the muscarinic acetylcholine receptor. (wikipedia.org)
  • Muscarine Muscarinic acetylcholine receptor Muscarinic antagonist Nicotinic acetylcholine receptor Nicotinic agonist Nicotinic antagonist Fisher A, Brandeis R, Bar-Ner RH, Kliger-Spatz M, Natan N, Sonego H, Marcovitch I, Pittel Z (2002). (wikipedia.org)
  • Name 2 natural alkaloids that are choinergic agonists and the receptor they target. (flashcardmachine.com)
  • It may be an agonist or partial agonist for a particular receptor, promoting a receptor-mediated biological response, often by competing with another substance (usually the natural or native substance) at the same receptor. (thefreedictionary.com)
  • Abstract -Moxonidine is an I 1 -imidazoline receptor agonist that reduces blood pressure in hypertensives. (ahajournals.org)
  • Applying the non-hydrolyzable cholinergic agonist carbachol (CCh) to the cerebral ganglion of Aplysia elicits sustained, regular bursts of activity in the buccal ganglia resembling those seen during biting. (nih.gov)
  • Carbachol is a potent cholinergic (parasympathomimetic) agent which produces constriction of the iris and ciliary body resulting in reduction in intraocular pressure. (pharmacycode.com)
  • Lahiri, DK , Nall, C & Farlow, MR 1992, ' The cholinergic agonist carbachol reduces intracellular β-amyloid precursor protein in PC 12 and C6 cells ', Biochemistry International , vol. 28, no. 5, pp. 853-860. (elsevier.com)
  • This propulsive effect of the extract, similar to that of carbachol, was blocked in atropine-pretreated mice, a standard cholinergic antagonist. (springer.com)
  • Among nonphotic stimulants, a classic cholinergic agonist, carbachol, is known to have a strong and unique phase-resetting effect on the circadian clock: Intracerebroventricular carbachol treatment causes phase delays during the subjective early night and phase advances in the subjective late night, but the effects of this drug on the suprachiasmatic nucleus (SCN) in vivo and in vitro are still controversial. (bireme.br)
  • Agonists such as nicotine are mainly toxicological curiosities, rather than clinically useful drugs. (anaesthetist.com)
  • Conversely, in mice lacking the α7 nAChR, the decay rate, but not the amplitude, of nicotine-evoked cholinergic and glutamatergic transients was attenuated. (jneurosci.org)
  • Substantiating the role of α7 nAChR in controlling the duration of release events, stimulation of α7 nAChR produced cholinergic transients that lasted 10- to 15-fold longer than those evoked by nicotine. (jneurosci.org)
  • The present experiments used mice lacking *β2* or α7 nAChRs to test the hypotheses that the generation of fast cholinergic transients requires stimulation of α4β2* nAChRs, that α4β2* nAChR stimulation evokes glutamate release, that the presence of thalamocortical inputs is necessary for generating cholinergic transients, and that the slow decay rate of cholinergic signals evoked by nicotine is primarily attributable to stimulation of α7 nAChRs. (jneurosci.org)
  • It has been shown that neurocognitive deficits in schizophrenia improve by administration of nicotine, nicotinic agonists or cigarette smoking. (clinicaltrials.gov)
  • Varenicline (VAR), an α4β2 nAChR partial agonist, approved for smoking cessation, mimics the effect of nicotine by stimulating nAChRs, and releasing sufficient dopamine in order to reduce craving and withdrawal effects. (clinicaltrials.gov)
  • Therefore, we studied the effects of cholinergic and adrenergic agents on the adenylate cyclase activity of the pericytes isolated from retinal microvessels. (healthdocbox.com)
  • A selective beta-1-adrenergic partial agonist. (molecularstation.com)
  • Evidence for adrenergic mediation of cholinergic inhibition of prolactin release. (semanticscholar.org)
  • Adrenergic agonists and their clinical uses. (helsinki.fi)
  • The muscarinic cholinergic antagonist atropine significantly blunted the ACTH response to arecoline. (euc.ac.cy)
  • A spasmolytic effect was also observed in other gut preparations either as noncompetitive inhibition of agonist dose-response curves, inhibition of high K + (80 mM)-induced contractions, or displacement of Ca 2+ dose-response curves to the right, indicating a calcium antagonist effect. (springer.com)
  • An antagonist is a molecule that interferes with or prevents the action of the agonist. (thefreedictionary.com)
  • Because it is a partial agonist (DRUG PARTIAL AGONISM) it acts like an agonist when sympathetic activity is low and as an antagonist when sympathetic activity is high. (molecularstation.com)
  • Evidence suggested that desensitization, most prominently observed with carbamylcholine, restricted the duration of cholinergic inhibition of the pacemaker on the 6th incubation day. (aspetjournals.org)
  • We tested whether the cerebral blood flow (CBF) response to the cholinergic agonist oxotremorine (OXO) is affected by the choice of anesthetics in dogs. (elsevier.com)
  • The cholinergic agonist oxotremorine did not modify the basal activity of adenylate cyclase but was able to decrease by almost 50% the forskolin-induced increase of camp. (healthdocbox.com)
  • At cholinergic synapses there is also a presynaptic transporter - the difference is that ACh is first hydrolysed back to acetate and choline, and then choline is avidly taken up. (anaesthetist.com)
  • 2-4 Subsequent discoveries of reduced choline uptake, 5 ACh release 6 and loss of cholinergic perikarya from the nucleus basalis of Meynert 7 confirmed a substantial presynaptic cholinergic deficit. (bmj.com)
  • Using choline as a nAChR partially subtype-specific agonist, we found that the majority of DS GCs demonstrated responses to choline while under synaptic blockade. (cambridge.org)
  • Because choline is a partial agonist for α3β4 nAChRs (Alkondon et al. (cambridge.org)
  • Clinical trials of other cholinergic compounds have shown that the AD patient population frequently tolerates drugs quite differently from healthy volunteers (Cutler et al. (springer.com)
  • These are the drugs which increase cholinergic transmission and therefore produce all the similar effects shown by parasympathetic system. (egpat.com)
  • What are the classes and subclasses of Cholinergic drugs? (flashcardmachine.com)
  • This article examines the existing scientific applicability of the original cholinergic hypothesis of Alzheimer's disease by describing the biochemical and histopathological changes of neurotransmitter markers that occur in the brains of patients with Alzheimer's disease both at postmortem and neurosurgical cerebral biopsy and the behavioural consequences of cholinomimetic drugs and cholinergic lesions. (bmj.com)
  • Many drugs are agonists having an effect similar or identical to natural body agonists. (thefreedictionary.com)
  • Activation of this "cholinergic antiinflammatory pathway" inhibits the production of TNF and other cytokines and protects animals from the inflammatory damage caused by endotoxemia and severe sepsis. (pnas.org)
  • The efferent neural signaling pathway is termed the cholinergic antiinflammatory pathway. (jci.org)
  • Convergent findings from neuroimaging and behavioral studies in both animals and humans suggest that the cholinergic system might also be critically implicated in selective attention by modulating cortical function via widespread projections from the basal forebrain. (frontiersin.org)
  • To examine the site on the HPA axis that is stimulated by cholinergic agents, we evaluated the in vivo and in vitro effects of the muscarinic cholinergic agonist arecoline in intact and pituitary stalk-transected rats as well as on isolated rat hypothalami, dispersed anterior pituicytes, and adrenocortical cells in culture. (euc.ac.cy)
  • These data suggest that the muscarinic cholinergic agonist arecoline stimulates the HPA axis in the rat and that this effect is mediated mainly by the release of endogenous CRH. (euc.ac.cy)
  • Cholinergic agonists inhibit cytokine synthesis and protect against cytokine-mediated diseases. (jci.org)
  • Because somatostatin is a strong inhibitor of insulin secretion, we hypothesized that cholinergic input to the δ-cell indirectly regulates β-cell function. (diabetesjournals.org)
  • Endogenous cholinergic signaling therefore provides direct stimulatory and indirect inhibitory input to β-cells to regulate insulin secretion from the human islet. (diabetesjournals.org)
  • whereas cholinergic blockade (e.g., by scopolamine) can severely interfere with attention and increase distraction (see e.g. (frontiersin.org)
  • Xanomeline tartrate [3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-l-methylpyridine tartrate], also known as LY246708 tartrate, is a potent and selective M1 agonist that crosses the blood brain barrier in animals and is orally bioavailable (Eli Lilly, unpublished data). (springer.com)
  • M3 agonist which is more selective, potent in action at the salivary and lacrimal glands than others. (flashcardmachine.com)
  • Cevimeline (AF102B) (Evoxac ) is a muscarinic agonist that is a Food and Drug Administration (FDA)-approved drug and used for the management of dry mouth in Sjögren's syndrome. (wikipedia.org)
  • The purpose of this study is to determine the composition of nAChRs necessary for nicotinic signaling in monocytic cells and to test the hypothesis that common metabolites of phosphatidylcholines, lysophosphatidylcholine (LPC) and glycerophosphocholine (G-PC), function as nAChR agonists. (frontiersin.org)
  • nAChR agonists enhance attentional performance primarily by increasing the probability and efficacy of cue detection. (jneurosci.org)
  • The cortical cholinergic input system is a critical component of forebrain circuitry mediating attention processes. (jneurosci.org)
  • Cortical cholinergic denervation resulting from degeneration of the nucleus basalis of Meynert (NBM) is a primary contributor to cognitive impairment and neuropsychiatric symptoms in the Lewy body diseases Parkinson's disease (PD), Parkinson's disease dementia (PDD), and dementia with Lewy bodies (DLB). (nih.gov)
  • The authors review the current landscape of pharmacological and surgical therapies for mitigating the cortical cholinergic deficiency in PD, PDD, and DLB. (nih.gov)
  • Targeting the basal forebrain with either deep brain stimulation (DBS)- or cell-based therapies is another strategy to mitigate cortical cholinergic deficiency. (nih.gov)
  • Cholinergic agents may allow early resolution of pseudo-obstruction and obviate surgery. (medscape.com)
  • Treatment of Disorders Characterized by Reversible Airway Obstruction in Childhood: are Anti-cholinergic Agents the Answer? (eurekaselect.com)
  • In the article, a short review of 'bad guys' including anticholinergics, selegiline, tolcapone and dopamine agonists, is given. (nih.gov)
  • Muscarine mimics the function of the natural neurotransmitter acetylcholine in the muscarinic part of the cholinergic nervous system, despite the less flexible structure due to the five-membered ring in the molecular skeleton. (wikipedia.org)
  • Cholinergic agonist medications stimulate the involuntary nervous system. (sharecare.com)
  • More specifically, it explores neurochemical interactions by focusing on the relationship between cholinergic and monoaminergic mechanisms in the central nervous system. (elsevier.com)
  • Organized into six sections comprised of 18 chapters, this volume begins with an overview of various models of cholinergic-monoaminergic and other chemical interactions, based in part on interactive processes that are believed to operate in the peripheral nervous system. (elsevier.com)
  • Cutler N.R., Sramek J.J., Seifert R.D., Conrad J.J., Wardle T.S. (1995) The Safety and Tolerance of Xanomeline Tartrate, an M1-Specific Cholinergic Agonist, in Patients with Alzheimer's Disease. (springer.com)
  • The cholinergic system has been recognized as playing an important role not only in several forms of dementia besides Alzheimer's Disease, but also in other CNS degenerative and psychiatric disorders. (routledge.com)
  • Cholinergic Synaptic Terminations in the Cerebral Cortex, Trophic Factor Dependency and Vulnerability to Aging and Alzheimer's Pathology. (routledge.com)
  • Accordingly, although there is presently no "cure" for Alzheimer's disease, a large number of potential therapeutic interventions have emerged that are designed to correct loss of presynaptic cholinergic function. (bmj.com)
  • If you have asthma, cholinergic agonists may not be good options for you. (sharecare.com)
  • Cardioinhibition persisted throughout the 5-minute exposure to cholinergic agonists in sinoatrial preparations from the 12th and l8th incubation days whereas automaticity recovered completely within 1 to 2 minutes in preparations from the 6th incubation day. (aspetjournals.org)
  • These data indicate that Zo.Cr contains a cholinergic, spasmogenic component evident in stomach fundus preparations which provides a sound mechanistic insight for the prokinetic action of ginger. (springer.com)
  • 1. What is the difference b/t a direct-acting and indirect-acting cholinergic agonist? (brainscape.com)
  • 18. What are the different chemical groups of indirect-acting cholinergic agonists? (brainscape.com)
  • Cholinergic suppression specific to intrinsic not afferent fiber synapses in rat piriform (olfactory) cortex. (semanticscholar.org)
  • There are some similarities between noradrenergic synapses (discussed in the previous web-page ) and cholinergic ones. (anaesthetist.com)
  • Prefrontal α4β2* nAChRs play a key role in evoking and facilitating the transient glutamatergic-cholinergic interactions that are necessary for cue detection and attentional performance. (jneurosci.org)
  • Removal of cholinergic inputs to the cortex permanently impairs attentional performance. (jneurosci.org)
  • Here we asked whether deficits in spatial attention associated with neglect could partly result from a cholinergic deafferentation of cortical areas subserving attentional functions, and whether such disturbances could be alleviated by pro-cholinergic therapy. (frontiersin.org)
  • Such studies have resulted in the discovery of an association between a decline in learning and memory, and a deficit in excitatory amino acid (EAA) neurotransmission, together with important roles for the cholinergic system in attentional processing and as a modulator of EAA neurotransmission. (bmj.com)
  • The Contribution of the Basal Forebrain Cholinergic System to Neuronal Plasticity. (routledge.com)
  • Numerous findings in rodents and primates point to a critical role of cholinergic inputs to cortical areas, which are conveyed by the basal forebrain cholinergic nuclei through widespread projections and act to enhance selective attention. (frontiersin.org)
  • Several lines of experimental evidence suggest that acetylcholine and other cholinergic agonists are excitatory to the hypothalamic-pituitary-adrenal (HPA) axis. (euc.ac.cy)